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This study is the ﬁrst in the literature to focus attention on the possible immunotoxic effect of integerri-
mine N-oxide content in the butanolic residue (BR) of Senecio brasiliensis, a poisonous hepatotoxic plant
that contains pyrrolizidine alkaloids (PAs). PAs have been reported as a pasture and food contaminant
and as herbal medicine used worldwide and are responsible for poisoning events in livestock and human
beings. After the plant extraction, BR extracted from Senecio brasiliensis was found to contain approxi-
mately 70% integerrimine N-oxide by elemental and spectral analyses (1H and 13C NMR), which was
administered to adult male Wistar Hannover rats at doses of 3, 6 and 9 mg/kg for 28 days. Body weight
gain, food consumption, lymphoid organs, neutrophil analysis, humoural immune response, cellular
immune response and lymphocyte analysis were evaluated. Our study showed that integerrimine N-
oxide could promote an impairment in the body weight gain, interference with blood cell counts and a
reducing T cell proliferative activity in rats; however, no differences in the neutrophil activities, lympho-
cytes phenotyping and humoural and cellular immune responses were observed. It is concluded that
doses of integerrimine N-oxide here employed did not produce marked immunotoxic effects.
 2011 Elsevier Ltd. Open access under the Elsevier OA license. 1. Introduction the milk from poisoned dairy cattle (Dickinson, 1980; MolyneuxPyrrolizidine alkaloids (PAs) are natural phytotoxins found in
thousands of plant species around the world. It is estimated that
PAs are present in about 3% of all ﬂowering plants (Roeder, 1995;
Smith and Culvenor, 1981). Currently, about 660 PAs and their
N-oxide derivatives are known, and half of them present toxic prop-
erties (Molyneux and Panter, 2009; Roeder, 1995, 2000; Stegelmeier
et al., 1999; Trigo, 2010).
Plants with PAs are common causes of natural poisonings that
affect livestock, wild animals (Lucena et al., 2010) and humans, as
people consume traditional herb prescriptions, such as bush-tea
in Jamaica (Bras et al., 1961; Brooks et al., 1970) or herbal medi-
cines. These herbal products, such as those that contain Symphytum
ofﬁcinalis (commonly called comfrey), Heliotropium indicum and
Eupatorium cannabinum, are known to contain PAs and have been
reported to cause intoxication events in industrialised countries
such as USA and UK (Fu et al., 2002; Mei et al., 2010; Stickel and
Seitz, 2000; Roeder and Wiedenfeld, 2009). Indirect intoxication
can also occur by the ingestion of contaminated foodstuff, such asx: +55 11 4033 6428.
sevier OA license. and James, 1990), eggs from poultry that has consumed PA-contam-
inated grain (Edgar and Smith, 1999) or even honey produced by
bees who pollinate contaminated ﬁelds (Boppré et al., 2005;
Deinzer et al., 1977; Kakar et al., 2010). Thus, PA exposure is a
problem for both veterinary and public health.
Among plants that contain PAs as a constituent, some genera are
especially important, such as Senecio, which contains many species
of worldwide concern. For example, common groundsel (S. vulgaris,
L.) has been found to contaminate salads (e.g., ready-packed rucola
and salad mixtures) in Middle Europe. Additionally, tansy ragwort
(Jacobaea vulgaris syn. Senecio jacobaea, L.) is a common Western
European plant inadvertently introduced into Eastern Europe,
Australia, New Zealand and the north-western regions of North
America. S. jacobaea from North America and S. brasiliensis from
Brazil have been discussed recently due to their extensive expan-
sion into pastures, which has led to a great number of horse and
cattle intoxications (Lucena et al., 2010; Stegelmeier et al., 2009;
Wiedenfeld and Edgar, 2010).
PAs produced by Senecio spp. are ester alkaloids derived from
necines, retronecine and otonecine. However, these agents must
be transformed into a pyrrole compound by microsomal liver
enzymes to become the active toxic molecule, which possesses a
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and absorption, PAs are ﬁrst hydroxylated by hepatic monoxygen-
ases of cytochrome P-450 into an unstable compound that rapidly
dehydrates to didehydropyrrolizidine alkaloids, resulting in a
spontaneous rearrangement to an aromatic pyrrole system. These
pyrrole compounds generate stabilised carbonium ions by the loss
of hydroxyl groups that react rapidly with nucleophilic mercapto,
hydroxyl and amino groups on proteins and the amino groups of
purine and pyrimidine bases in nucleosides like DNA and RNA. In
addition, the hydrolysis of didehydropyrrolizidine alkaloids results
in pyrrole compounds with alkylating activity towards DNA, pro-
teins and cysteine residues (Culvenor et al., 1969, 1971). Based
on these reports, it is not surprising that pyrrole compounds can
damage proteins, RNA and DNA, resulting in protein synthesis
impairment, cellular function loss, tumour development and an
anti-mitotic effect. Indeed, it is well established that PAs can pro-
mote megalocytosis, carcinogenesis and teratological effects (Fu
et al., 2004; Mattocks and Cabral, 1984; Petry et al., 1984).
While the toxic effects of PAs on different organ systems,
namely the liver, are amply covered, very little is known about
the possible toxic effects of PAs on the immune system, a system
highly dependent on protein synthesis and lymphocyte prolifera-
tion to establish a vigorous functional immune response. Thus,
the purpose of the present study was to investigate the potential
immunotoxic effects of PAs from S. brasiliensis on different
branches of the immune response in rats.
2. Materials and methods
2.1. Plant material
Leaf samples of S. brasiliensiswere collected in Pelotas, Rio Grande do Sul, Brazil,
in February 2008. A voucher specimen was deposited in the Federal University of
Pelotas Herbarium, Brazil, under the number 24592 and was identiﬁed as Senecio
brasiliensis (Spreng.) Less. var. brasiliensis. Dry leaf samples of S. brasiliensis
(900 g) were macerated in 92% ethanol for 3 days. After total solvent evaporation
under reduced pressure at 40 C, an ethanol residue was obtained that was acidiﬁed
with 10% tartaric acid and ﬁltered to obtain a waxy residue and an acidic solution.
This solution was consecutively fractionated with ethyl acetate and chloroform to
obtain an ethyl acetate and chloroform solution. Total solvent evaporation was per-
formed under reduced pressure at 40 C to achieve both residues: the ethyl acetate
residue and the chloroform acid residue. Subsequently, the remaining acidic aque-
ous solution was alkalised with 0.5 M ammonium hydroxide (NH4OH) to pH 9–10
and was extracted consecutively with chloroform and n-butanol saturated with
water. The chloroform and butanol solutions were evaporated completely for their
waste products, chloroform alkaline and butanolic residue (BR).
These residues were submitted to elemental and spectral analyses (1H and 13C
NMR), which were performed at the Analytical Laboratory of the Institute of Chem-
istry, University of São Paulo and revealed the presence of integerrimine N-oxide
only in the BR. The 1H and 13C spectral data of the BR were consistent with previ-
ously reported ﬁndings by Reina et al. (2001). From these results, the purity of
the extracted product was determined to be 69%. Thus, the doses employed in
the present study of 3, 6 and 9 mg BR per kilogram of body weight contained
2.07, 4.14 and 6.21 mg, respectively, of integerrimine N-oxide.
2.2. Animals
Male adult Wistar Hannover rats (10 weeks of age) were obtained from our col-
ony in the Department of Pathology, School of Veterinary Medicine and Animal Sci-
ences, University of São Paulo. All rats were housed separately and received food
(Nuvilab CR1 – balanced rodent feed produced as recommended by the National
Research Council and National Institute of Health – USA) and water ad libitum
and were maintained under controlled conditions of temperature (22–25 C), rela-
tive humidity (50–65%) and lighting (12 h/12 h light/dark cycle). Cages were
checked daily until the end of the experimental period for rats’ clinical signs, soft
faeces, food waste and mortality. Food consumption and body weight gain were
measured every 3 days. Experiments were performed in accordance with the ethical
principles for animal research adopted by the Bioethics Committee of the School of
Veterinary Medicine and Animal Sciences (process 1461/2008).
2.3. Reagents
Dichloroﬂuorescein diacetate (DCFH-DA) was obtained from Molecular Probes.
Concanavalina a (ConA), freund’s complete adjuvant (FCA), lipopolysaccharide (LPS
0127:B8), peroxidase, phorbol myristate acetate (PMA), propidium iodide (PI),RNAse A and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma
Chemical Co. Foetal bovine serum (FBS), HEPES, RPMI culture medium-1640 and
trypan blue were obtained from Gibco. Keyhole limpet hemocyanin (KLH) was ob-
tained from Calbiochem. FITC-labelled anti-CD3 (clone G4.18), PE-labelled anti-CD4
(clone OX-35), PerCP-labelled anti-CD8a (clone OX-8), PE-labelled anti-IgM (clone
G53-238), FITC-labelled anti-CD45R (clone HIS24) and puriﬁed anti-CD32 (clone
D34-485) Rat BD Fc Block™ antibodies were purchased from BD Pharmingen.
2.4. Lymphoid organs, serum biochemistry and neutrophil granulocyte evaluation
Twenty-eight rats were randomly divided into one control and three experi-
mental groups. Rats from experimental groups were treated once daily with 3, 6
or 9 mg BR/kg body weight by gavage for 28 days. On day 29, all rats were anaesthe-
tised for blood collection from the caudal cava vein, and after euthanasia by cervical
dislocation, lymphoid organs (thymus and spleen) were harvested for lymphoid
organ analysis.
Blood collection was performed with or without heparin to evaluate haemato-
logical and neutrophil parameters and serum biochemical analyses, respectively.
The haematological parameters were assessed by automatic Horiba ABX equip-
ment. Serum biochemistry was analysed using a Roche Hitachi 917 analyser with
corresponding reagents. The measured markers were serum albumin, total protein,
alkaline phosphatase (AP), alanine transaminase (ALT), aspartate transaminase
(AST), and c-glutamyl transpeptidase (GGT).
To perform neutrophil granulocyte analysis, blood samples (100 lL) were di-
rectly used to analyse the phagocytic activity and the oxidative burst of neutrophil.
The method of analysis was adopted from Hasui et al. (1989). To analyse the oxida-
tive burst, cells obtained from each rat (2  105 cells/tube) were incubated for
30 min at 37 C with either dichloroﬂuorescein diacetate (DCFH-DA) or
DCFH-DA + phorbol myristate acetate (PMA) or DCFH-DA + Staphylococcus aureus
conjugated with propidium iodide (SAPI). To analyse the phagocytic activity, cells
were incubated for 30 min at 37 C with either SAPI or DCFH-DA and SAPI. Ten
thousand neutrophils were then acquired by ﬂow cytometry (FACS Calibur FACSCal-
ibur™ ﬂow cytometer equipped with Cell Quest Pro software (Becton Dickinson
[BD] Immunocytometry System), and the data were analysed using FlowJo 7.2.2
software (Tree Star Inc, Ashland, KY).
For lymphoid organ analysis, the thymus and spleen were removed from
euthanised rats and weighed. The spleen was disrupted with two pieces of ground
glass, and the red blood cells were removed by lysing with a 0.4% ammonium chlo-
ride esterile solution, resulting in a single splenocyte suspension in cold RPMI-1640
culture medium. Bone marrow cell suspensions were achieved by ﬂushing the mar-
row cavity of the left femur of each rat with ice-cold RPMI-1640 medium using a
sterile syringe with a 26-gauge needle. Viability was assessed via a trypan blue
dye exclusion test, and cell numbers were determined by a haemocytometer. More-
over, fragments of liver, spleen, thymus, lungs, and kidney were collected and ﬁxed
in 10% formalin, routinely embedded in parafﬁn, cut into 5-lm thick sections and
stained with haematoxylin and eosin (HE) for histopathology.
2.5. Humoural immune response
Forty rats were randomly divided into one control and three experimental
groups. Rats from experimental groups were treated once a day with 3, 6 or
9 mg BR/kg body weight by gavage for 28 days. On Day 21 of their regimens, subsets
of rats (n = 10/treatment group) were immunised by intraperitoneal (IP) injection of
2.0  109 sheep red blood cell (SRBC) in 0.9% saline (normal saline). Seven days later,
blood samples were harvested from the euthanised rats, allowed to clot in a vertical
tube at room temperature for 45 min and then were separated by centrifugation at
3200g for 10 min. The serumwas collected, and the anti-SRBC antibody titrewas esti-
mated as follows: 25 lL of twofold diluted serum in normal saline was challenged
with 25 lL 1% (v/v) SRBC suspension in a microtitre plate. The plate was incubated
at 37 C for 1 h and then checked for haemagglutination, and the highest dilution
causing haemagglutination was taken as the antibody titre. Antibody titres were ex-
pressed in a gradedmanner,with theminimumdilution (i.e., 1/2) being ranked as ‘‘1’’
against which the mean ranks of the different groups were compared.
The Plaque-Forming Cell assay (PFC) was also used to assess the status of the
humoural immune response of each host. Brieﬂy, rat spleens were used to generate
a corresponding single-cell suspension (107 cells/mL) in RPMI-1640 medium at
4 C. The splenocyte suspension, SRBC, and guinea pig complement were added to a
1.0-cm2 PFC well to achieve a ﬁnal concentration of 2.0  106 splenocytes/mL, 7%
SRBC, and 10% complement in a ﬁnal volume of 50 lL; duplicatewells were prepared
for each rat sample. The wells were then covered with glass slides (22  22 mm) and
sealedwith varnish. EachPFCwellwas incubatedat 37 C for 3 hbefore thenumber of
lysate plaques produced by the 105 splenocytes in thewell was counted under a light
microscope (40magniﬁcation). Data are expressed as the total PFC/106 splenocytes.
2.6. Cellular immune response (delayed type hypersensitivity; DTH)
Forty rats were randomly divided into one control and three experimental
groups. Rats from experimental groups were treated once a day with 3, 6 or
9 mg BR/kg body weight by gavage for 28 days. Sensitisation with KLH was per-
formed as described by Exon et al. (1990). Brieﬂy, KLH (5 mg/mL) was injected into
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Fig. 1. Body weight of rats treated or not with the butanolic residue of Senecio
brasiliensis by gavage for 28 days over the experimental period. Only means were
showed.
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tal period (Day 28), all the rats were challenged with heat-aggregated KLH (80 C for
1 h) in 0.1 mL saline (20 mg/mL). The challenge antigen was injected into one foot-
pad, with the other footpad receiving sterile saline. Swelling was measured with a
metric tape and calculated by subtracting the thickness of the saline-injected left
footpad from that of the KLH-injected right footpad thickness. The swelling was
then plotted as the difference between the measurements.
2.7. Lymphocytes analysis
Forty rats were randomly divided into one control and three experimental
groups. Rats from experimental groups were treated once a day with 3, 6 or
9 mg BR/kg body weight by gavage for 28 days. At the end of the experimental per-
iod, the animals were euthanised. The spleen was teased between two frosted
slides, and the tissue dispersion was separated by centrifugation at 260g at 4 C
for 10 min. The supernatant was discarded, and the pellet was resuspended in
3 mL red blood cell lysis buffer containing 0.83% NH4Cl in 100 mM Tris buffer, pH
7.4 and maintained at room temperature for 3 min. The cells were washed three
times with medium and suspended into 1 mL of the medium containing 10% FBS.
Lymphocyte proliferation was performed in triplicate as previously described
(Mosmann, 1983). Brieﬂy, 100 lL splenocytes standardised at 2  106 cell/mL were
pipetted into wells of a 96-well microtiter plate. To each well was added either no
mitogen or ConA or LPS at a ﬁnal concentration of 5 lg/mL. After incubating for 48 h
at 37 C in a 5% CO2 humidiﬁed incubator, cell proliferation was determined by MTT
assay. Brieﬂy, 10% 3-(4,5-diamethyl-2-thiazolyl) 2,5-diphenyl-2H-tetrazolium
(MTT; 5 mg/mL) was added to each well and incubated at 37 C in a 5% CO2 humid-
iﬁed incubator for 4 h. The blue formazan precipitate was then dissolved in acidic
isopropanol, and its optical density was measured at 570 nm using a microtitre
plate reader (PowerWave HT, BioTek). The proliferation index (PIX) was calculated
as follows: PIX = Absorbance of stimulated cells/Absorbance of unstimulated cells.
Spleen cell phenotyping was performed as previously described (Kubosaki et al.,
2008). To separate non-adherent splenocytes from the adherent ones, the remaining
splenocyte solutions were incubated in 6-well plates for 2 h at 37 C in a 5% CO2
humidiﬁed incubator. After this period, the non-adherent cells were harvested,
washed with RPMI and then adjusted to 1 106 cells and incubated with 0.5 lL Rat
BD Fc Block for 5 min to block the Fc-mediated adherence of antibodies prior to stain-
ingwith speciﬁc antibodies. Anti-CD3, anti-CD4 and anti-CD8 antibodieswere used to
detect T lymphocytes and anti-IgM and anti-CD45R for B lymphocytes, and the cells
were incubated for 30 min at 4 C in the dark. The cells were then washed to remove
unbound antibody and then were resuspended in PBS for ﬂow cytometric collection
using a FACSCalibur™ﬂowcytometer equippedwith Cell Quest Pro software (Becton
Dickinson [BD] Immunocytometry System). A total of 10,000 target cells were col-
lected by ﬂow cytometry, and the results were expressed as a percentage. Data anal-
yses were performed with FlowJo 7.2.2 software (Tree Star Inc, Ashland, KY).
2.8. Cell cycle analysis
Splenic cell suspensions were prepared from eight untreated rats as outlined
above. The treatment with integerrimine in vitro was performed in quadruplicates
at the same doses proposed by Santos-Mello et al. (2002). Brieﬂy, BR was added to
the cultures (2  105 cells/well) at ﬁnal concentration of 0.12 and 1.2 mg/mL, which
corresponds to 0.08 and 0.8 mg/mL of integerrimine N-oxide, respectively. Cultures
of splenocytes without BR represented negative control. In order to induce prolifer-
ation of lymphocytes, it was added ConA at a ﬁnal concentration of 1 mg/mL. After
incubating for 72 h at 37 C in a 5% CO2 humidiﬁed incubator, lymphocytes were
ﬁxed in 70% ethanol for 2 h at 20 C to prepare them for cell cycle analysis.
Next, the cells were washed twice in PBS (5 min, 2000 rpm) and incubated with
200 lL of PI solution (20 lg/mLpropidium iodide, 200 lg/mLRNAseAand0.1% triton
(v/v) in PBS) for 15 min at 37 C. Then, 10,000 eventswere acquired fromeach sample
in a FACS Calibur Flow Cytometer equipped with Cell Quest Pro software (Becton
Dickinson [BD] Immunocytometry System). Data analyses were performed using
FlowJo 7.2.2 software (Tree Star Inc, Ashland, KY) and data presented as percentage.
2.9. Statistical analysis
The data were analysed using GraphPad Prism 5.00 software (GraphPad Soft-
ware, Inc., San Diego, CA) by one-way analysis of variance (ANOVA) followed by
Dunnett’s test for multiple comparisons. Nonparametric data from three or more
groups were compared by the Kruskal–Wallis test followed by Dunn’s test. Data
are expressed as the mean ± standard error of the mean (SEM), and differences were
considered statistically signiﬁcant at p < 0.05.
3. Results
3.1. Daily food consumption, body weight gain and lymphoid organ
evaluation
During the experimental design, none of the rats from the
experimental groups showed soft faeces, depression, neurologicalsigns or mortality. No leftover food or gnawed feed were found into
cages of all animals. Fig. 1 illustrates the body weight of rats from
all groups over the experimental period; it is possible to notice a
prejudice of BR treated groups to gain weight. However, while only
rats treated with 6 mg/kg BR showed decreased food consumption
during all period, animals of all groups exposed to the plant residue
showed a reduction in body weight gain when compared to the
rats from the control group (Table 1). Rats treated with the higher
dose of BR also manifested an increased spleen relative weight
compared to the control rats; however, the thymus relative weight
or spleen and bone marrow cellularities in these rats were not sta-
tistically different (Table 1). Histologically, no morphological alter-
ations in lymphoid organ architecture were observed in animals of
all groups studied; nevertheless, rats treated with 9 mg/kg BR
showed a mild-to-moderate splenic blood congestion (Fig. 2), a
mild megalocytosis in the liver, characterized by cytoplasmic and
nuclear enlargement of liver cells (Fig. 3) and hepatic and renal
blood congestion. No other morphological alterations were ob-
served in other organs.
3.2. Biochemical and haematological parameters
Table 2 shows the hepatic enzyme activity in rats treated with
the BR for 28 days. Compared with untreated animals, the AST
and ALT levels in rats treated with 6 and 9 mg/kg BR were statisti-
cally different.
Table 3 shows the blood parameters of control rats and those
treated with the BR of S. brasiliensis, which signiﬁcantly increased
the RBC and WBC counts (neutrophil and lymphocyte) in rats ex-
posed to the higher dose of the plant residue compared to the con-
trol group.
3.3. Neutrophil granulocyte evaluation
The statistical test employed did not show any signiﬁcant dif-
ferences between the groups of animals, as shown in Table 4.
3.4. Immune response and lymphocyte phenotype
In both assays employed to measure the humoural immune re-
sponse (antibody titre measurement and the PFC assay), no
signiﬁcant differences were observed between control and treated
animals. Similarly, the BR in all doses administered did not pro-
mote any signiﬁcant changes in the cell-mediated immune re-
sponse (i.e., DTH). Conversely, when spleen lymphocytes were
stimulated in vitrowith Con-A, a signiﬁcant reduction in the prolif-
erative index of lymphocytes from rats treated with the high dose
of the BR compared to those from control rats was observed
(Table 5).
Table 1
Effect of the butanolic residue of Senecio brasiliensis on total food consumption, body weight gain and lymphoid organ relative weights and cellularities of rats.
Treatment
(n = 7/group)
Total food consumption
(g)
Total body weight
gain (g)
Thymus relative
weighta
Spleen relative
weighta
Spleen
cellularityb
Bone marrow
cellularityc
Control 581.3 ± 16.8 108.4 ± 4.6 0.126 ± 0.010 0.253 ± 0.009 70.4 ± 5.3 15.6 ± 1.7
3 mg/kg 550.3 ± 13.6 76.9 ± 5.5** 0.114 ± 0.010 0.267 ± 0.009 67.5 ± 4.0 14.7 ± 1.4
6 mg/kg 508.4 ± 19.2* 60.6 ± 5.1*** 0.117 ± 0.013 0.282 ± 0.013 58.1 ± 6.9 12.8 ± 0.9
9 mg/kg 547.6 ± 27.1 48.1 ± 8.2*** 0.120 ± 0.012 0.292 ± 0.009* 54.4 ± 7.1 12.3 ± 0.4
Data are expressed as mean ± SEM.
a g/100 g of body weight.
b number of splenocytes  106/g of spleen.
c number of nucleated cells  106/mL.
* p < 0.05 versus control group.
** p < 0.01 versus control group.
*** p < 0.001 versus control group.
Fig. 2. Spleen section of rat from the control group (a) and from the group treated
with 9 mg/kg of the butanolic residue of Senecio brasiliensis by gavage for 28 days
(R: red pulp; W: white pulp). Note the blood congestion in both red and white pulp
of spleen from rat treated with the residue of the plant. H.E., 10X.
Fig. 3. Liver section of rat from the control group (a) and from the group treated
with 9 mg/kg of the butanolic residue of Senecio brasiliensis by gavage for 28 days.
Note the hepatic blood congestion (arrowhead) of the rat treated with the residue of
the plant and the presence of cytoplasmic and nuclear enlargement of liver cells
(megalocytosis) (arrow). H.E., 40X.
2316 F. Elias et al. / Food and Chemical Toxicology 49 (2011) 2313–2319The percentages of CD45R+IgM+, CD3+CD4+ and CD3+CD8+ cells
did not differ signiﬁcantly between BR-treated and control rats. In
addition, BR treatment did not affect the CD4/CD8 ratio compared
to those from the control group (Fig. 4).
3.5. Effects of integerrimine N-oxide in vitro on the lymphocyte cell
cycle
Integerrimine N-oxide induced G1 arrest and reduced prolifera-
tion in lymphocytes. This result was based on data showing that
the higher dose of BR induced a higher percentage of cells in the
G0/G1 phase. Consequently, we observed a signiﬁcant reduction
in the percentage of cells in the S phase (Fig. 5).4. Discussion
It is well established that the immune system is highly suscep-
tible to an inadequate supply of either macronutrients or selected
micronutrients. In fact, the most prevalent cause of immunodeﬁ-
ciency worldwide is severe malnutrition, which affects as much
as 50% of the population in some impoverished communities
(Cunningham-Rundles et al., 2005; França et al., 2009). In the pres-
ent study, all of the groups of animals treated with the BR of S. bra-
siliensis showed reduced food consumption, although rats treated
with 6 mg/kg of the plant showed a statistically signiﬁcant de-
crease in food intake. Thus, it could be hypothesised that food deﬁ-
ciency could produce an immunosuppressive effect and not the
plant treatment itself. Nevertheless, in the context of the malnutri-
tion-related immunodeﬁciency, the atrophic thymus works as a
‘‘barometer’’ of undernourishment (Chandra, 1992; Prentice,
1999). Thus, considering that a reduction in food consumption in-
duced by BR treatment did not promote any alteration in the thy-
mus relative weight in all rats evaluated, we can assume that all
immunotoxic effects reported here were due to the direct action
of S. brasiliensis.
In relation to total body weight gain, rats treated with the BR
presented an overwhelming impairment to gain weight, even
when their reduction in food consumption did not differ dramati-
cally between the control and experimental groups as seen in those
animals treated with the higher dose of the BR. Little could be spec-
ulated to explain this interesting result; however, Mingatto et al.
(2008) showed that fed rats treated with monocrotaline (MCT), a
PA present in plants of the Crotalaria species that causes hepato-
toxicity similar to that produced by Senecio alkaloids, exhibited in-
creased glycogenolysis and glycolysis. However, fasted rats
showed decreased gluconeogenesis and urea synthesis from
L-alanine. The authors concluded that MCT leads to a compensa-
tory lipolysis to generate energy, resulting in a reduction in body
weight gain. Thus, it is possible that this same mechanism could
Table 2
Effect of the butanolic residue of Senecio brasiliensis on biochemical parameters.
Treatment (n = 7/group) AST (U/L) ALT (U/L) AP (U/L) GGT (U/L) Total protein (g/dL) Albumin (g/dL)
Control 110.4 ± 8.8 43.2 ± 1.6 61.7 ± 2.7 1.31 ± 0.21 7.3 ± 0.1 4.2 ± 0.2
3 mg/kg 138.5 ± 5.9 51.8 ± 2.1 50.6 ± 4.1 0.85 ± 0.24 7.7 ± 0.2 4.6 ± 0.1
6 mg/kg 173.9 ± 13.3*** 85.0 ± 9.9** 52.1 ± 1.8 1.16 ± 0.42 8.0 ± 0.3 4.6 ± 0.1
9 mg/kg 157.4 ± 8.5** 86.1 ± 13.4** 53.3 ± 6.6 1.21 ± 0.19 7.6 ± 0.2 4.8 ± 0.1
Data are expressed as mean ± SEM.
AST, aspartate transaminase; ALT, alanine transaminase; AP, alkaline phosphatase; GGT, c-glutamyl transpeptidase.
** p < 0.01 versus control group.
*** p < 0.001 versus control group.
Table 3
Effect of the butanolic residue of Senecio brasiliensis on blood parameters of rats.
Treatment (n = 7/group) Haematocrit (%) RBC (106/mm3) WBC (103/mm3) Neutrophil Lymphocyte Monocyte
Control 42.3 ± 0.9 7.3 ± 0.2 8.2 ± 0.4 1.4 ± 0.1 6.4 ± 0.4 0.3 ± 0.1
3 mg/kg 43.1 ± 1.5 7.7 ± 0.2 10.2 ± 0.9 1.9 ± 0.2 8.0 ± 0.8 0.4 ± 0.1
6 mg/kg 39.2 ± 0.6 7.5 ± 0.1 9.6 ± 1.3 1.7 ± 0.4 7.6 ± 1.1 0.2 ± 0.1
9 mg/kg 42.3 ± 0.7 8.2 ± 0.1*** 13.3 ± 0.6** 3.3 ± 0.3*** 9.5 ± 0.6* 0.3 ± 0.1
Data are expressed as mean ± SEM.
RBC, red blood cells; WBC, white blood cell.
* p < 0.05 versus control group.
** p < 0.01 versus control group.
*** p < 0.001 versus control group.
Table 4
Neutrophil oxidative burst and phagocytosis of rats treated with the butanolic residue of Senecio brasiliensis.
Treatment (n = 7/group) Phagocytosis Oxidative burst (MFI) Oxidative burst induced
by phagocytosis (MFI)
Oxidative burst induced
by PMA (MFI)
% MFI
Control 81.2 ± 2.8 32.5 ± 2.7 123.8 ± 22.1 177.2 ± 45.5 290.5 ± 35.7
3 mg/kg 81.8 ± 2.8 31.8 ± 2.7 184.5 ± 38.4 169.5 ± 40.9 270.1 ± 27.8
6 mg/kg 75.3 ± 1.8 27.3 ± 2.3 220.4 ± 31.1 138.3 ± 23.4 220.8 ± 45.8
9 mg/kg 78.9 ± 3.7 31.3 ± 4.3 100.5 ± 6.2 114.1 ± 24.1 187.9 ± 25.9
MFI, median ﬂuorescence intensity; PMA, phorbol myristate acetate.
Table 5
Evaluation of immune responses of rats treated with the butanolic residue of Senecio brasiliensis.
Treatment (n = 10/group) PFC/106 splenocytes Anti-SRBC Titre (Log2) DTH (mm) Proliferation index
Con-A LPS
Control 84.4 ± 12.7 10.0 ± 0.6 4.7 ± 0.7 1.5 ± 0.1 1.5 ± 0.1
3 mg/kg 76.4 ± 10.5 10.3 ± 0.5 5.5 ± 0.6 1.4 ± 0.1 1.5 ± 0.1
6 mg/kg 80.9 ± 17.1 9.7 ± 0.6 5.5 ± 0.3 1.2 ± 0.1a 1.7 ± 0.0
9 mg/kg 99.5 ± 18.9 9.8 ± 0.6 5.4 ± 0.5 1.2 ± 0.1* 1.7 ± 0.1
Data are expressed as mean ± SEM.
a Only 8 sample cells were employed.
* p < 0.05 versus control group.
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ensis to explain the results shown here.
The impairment to gain weight could also be caused by a hep-
atotoxic effect of the S. brasiliensis residue, which was detected
as an enhancement in hepatic enzyme patterns (AST and ALT) in
serum from animals treated with the higher doses of the BR. How-
ever, it should be noted that despite statistical differences in these
hepatic enzymes between the control and treated groups, the
range of physiological variation of both enzymes in Wistar
Hannover rats is wide (Taconic Farms, 2005). In fact, a survey of
historical data from Sprague–Dawley rats considering reference
values of biochemical parameters, revealed that physiological
values of AST and ALT could enhance 3.5 and 6-fold the meanvalue, respectively (Petterino and Argentino-Storino, 2006). In
addition, no differences in GGT, albumin and total protein levels
were detected among the groups of animals. Moreover, the lesions
found in liver histopathological samples were mild, even in those
animals treated with the higher dose of the residue. Thus, the main
determinant of body weight loss cannot be hepatotoxicity.
While no statistical signiﬁcance was detected in the thymus rel-
ative weight of rats exposed to the BR, a signiﬁcant increase was
observed in the spleen relative weight in animals treated with
9 mg/kg BR. As no symptoms of infections or anaemia, myeloprolif-
erative disorders with extramedullary haematopoiesis ﬁgures and
hepatic disease were detected, which could result in spleen
enlargement (Nüßlein et al., 2009), it is plausible to suggest that
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Fig. 4. Spleen cell phenotypes of rats treated with the butanolic residue of
S. brasiliensis. Markers expressed as a percentage of total lymphocytes. Data are
expressed as mean ± SEM.
Fig. 5. Effects of integerrimine N-oxide in vitro on the lymphocyte cell cycle. It is
observed a higher percentage of cells in the G0/G1 phase and a signiﬁcant reduction
in the S phase in lymphocytes treated with higher dose of butanolic residue from
Senecio brasiliensis (⁄p < 0.05, post-test Dunn). Data are expressed as the mean
± SEM (n = 8).
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of splenic blood congestion as shown by the histopathological eval-
uation and not due to an immunotoxic effect of the plant.
When blood cell counts were analysed, an increased number of
certain cell types was detected in rats treated with 9 mg/kg BR of S.
brasiliensis. There are some pathological circumstances for an in-
crease in the blood cell mass; such as polycythemia vera, a myelo-
proliferative neoplasm characterised by an erythrocytosis that is
variably associated with leukocytosis and thrombocytosis, it has
to be differentiated mainly from the so-called secondary polycy-
themia that is muchmore common in clinical practice and, in some
cases, results from erythropoietin related to renal diseases (Patnaik
and Tefferi, 2009; Prchal, 2003). In fact, we veriﬁed that animals
treated with 9 mg/kg BR showed kidney congestion; however,
questions are raised as to whether the kidney lesions shown here
are enough to promote erythrocytosis. Also, it is unknown why
there were increased white blood cells counts when no enhanced
bone marrow cellularity or inﬂammatory process was detected.
The other condition that could produce this effect is dehydration
or hipovolemia (Watson, 2000), condition that could be ruled out
in the present study, once we found normal haematocrit values.
To promote their cytotoxic effects, PAs must be biotransformed
by hepatic microsomal enzymes into their highly reactive metabo-
lite, the pyrrole compound, which has high nucleophilic reactivity
with DNA and causes increased DNA binding and cross-linking
events (both DNA–DNA and DNA–protein) (Fu et al., 2001; Hincks
et al., 1991; Kim et al., 1993), all of which can readily lead to an
anti-mitotic state. This feature allows that some PAs, such as indi-
cine-N-oxide (found in Heliotropium indicum L.), could be employed
as antiproliferative chemotherapeutics to treat patients with leu-kaemia and solid tumours (Poster et al., 1981; Whitehead et al.,
1990). Furthermore, it was already demonstrated that in vivo
administration of integerrimine induces anti-mitotic action in
hepatocytes (Nardi et al., 1980) and even when used in vitro it
was able to reduce proliferation of lymphocytes (Santos-Mello
et al., 2002).
Taking into account that the response to DNA damage activates
checkpoint pathways that regulate speciﬁc DNA-repair mecha-
nisms and induce cell cycle arrest (Branzei and Foiani, 2008), it is
likely that the reduction in proliferative index of ConA stimulated
T lymphocytes from rats treated with higher BR dose observed here
could be the result of DNA damage induced by integerrimine. In
fact, the cell cycle analysis of ConA stimulated T Lymphocytes trea-
ted in vitro with BR conﬁrmed this hypothesis, since it was ob-
served G1 arrest and consequently reduction in percentage of
cells in the S phase. Moreover, Hueza et al. (2009) demonstrated
that MCT, the PA from Crotalaria spectabilis, induces a reduction
in bone marrow cellularity, reinforcing the theory of the antiprolif-
erative activity of PAs.
Regardless, no statistical difference was detected in the oxida-
tive burst activity among the different groups, BR treatment clearly
promoted an interference with the rapid generation and release of
reactive oxygen intermediates by neutrophils in a dose-dependent
fashion, even when a strong stimulus, such as the protein kinase C
ligand phorbol myristate acetate, was employed. Different from
the oxygen free radicals produced by aging, infections and direct
cytotoxicity, immune cells use NADPH oxidase to reduce O2 to free
radicals and then to hydrogen peroxide to combat infections
(Witko-Sarsat et al., 2000). This route is unlikely to be the target
of the mechanism of action of PAs; however, neutrophils them-
selves could be the target of the toxicity from free radicals formed
by PA exposure, therefore reducing its bactericidal property.
In relation to spleen cell phenotypes, it was not surprising that
no differences between lymphocyte subset cells were observed,
because we did not observe any lymphoid organs morphological
changes, relative weight and cellularity abnormalities in rats ex-
posed to BR of the plant.
This study is the ﬁrst in the literature that focused on the pos-
sible effect of integerrimine N-oxide content in the BR of S. brasil-
iensis on the immune system. Despite the impairment in the body
weight gain, interfere with blood cell counts and a reducing T cell
proliferative activity in rats, S. brasiliensis treatment did not pro-
mote marked immunotoxic effect.Conﬂict of Interest
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